Key points

  • Baker Bros. Advisors LP, a director at Kodiak Sciences Inc., reported buying $157.0 million of common stock. The purchases cover 1,941,755 shares and carry a transaction date of September 29th, 2026.
  • The buying was reported across 82 separate filings. That volume of paperwork points to a sustained accumulation program rather than a single block print.
  • Reported prices ran from $61.2104 to $89.8555. Kodiak Sciences last traded at $94.80, which sits above the top of that band.
  • The buyer is an institution, not an individual officer. Baker Bros. Advisors LP holds a director seat, so its trades are reported on Form 4 the same way an executive's would be.

Kodiak Sciences Inc. (KOD) disclosed insider purchases totaling $157.0 million, made by Baker Bros. Advisors LP in its capacity as a director of the company. The filings cover 1,941,755 shares with a transaction date of September 29th, 2026.

Kodiak Sciences carries a market capitalization of $5,958,128,640 and operates in biological products, excluding diagnostic substances. Against that market value, the reported purchase size is substantial in absolute dollars and sits among the larger single-name insider buys on the board.

What the filing shows

The Form 4 record attributes the buying to Baker Bros. Advisors LP, which is listed in a director role. The firm is an institution, and its reported transactions reflect activity across the funds and accounts it advises rather than a personal account.

The share count is 1,941,755 and the dollar total is $157.0 million. Reported execution prices span $61.2104 to $89.8555, which tells you the shares were not all acquired at one level. Eighty-two filings sit behind the total.

What the insiders did

The pattern here is accumulation spread over many reported transactions rather than one decisive strike. A buyer working through a price band that stretches from $61.2104 to $89.8555 has been paying up at times and filling in at lower levels at others.

It is worth separating the role from the mechanics. Baker Bros. Advisors LP holds a board seat, which is what brings these trades onto Form 4 at all. The filing record states what was bought, at what prices, and on what date. It does not state intent, and nothing in the paperwork speaks to the firm's reasoning.

For readers tracking institutional directors, the useful detail is that this is reported insider activity and not a quarterly 13F snapshot. Form 4 arrives on a short clock, so the information is closer to the trade than a position disclosure would be.

Where the price sits

Kodiak Sciences last changed hands at $94.80. That is above $89.8555, the highest reported purchase price in the disclosed range, and well above the $61.2104 bottom end. Anyone pricing this news against the tape is looking at a stock that has already moved past the levels in the filing.

That gap matters for how the disclosure is read. The purchases were made at prices that are no longer available, so the filing is a record of what an insider was willing to pay, not a guide to current entry levels.

What that leaves

Three facts carry the story. The dollar amount is $157.0 million. The share count is 1,941,755. The transaction date is September 29th, 2026, and the filing count is 82.

Set against a $5,958,128,640 market capitalization, the purchase represents a meaningful commitment of capital by a board-level holder. Biotechnology names in this sector often see concentrated holders with long time horizons, and a director that is also an investment adviser sits in both camps at once.

The limits are plain. The filings do not disclose a target holding size, do not indicate whether buying continued after the reported date, and do not explain the motivation behind any individual trade. What is on the record is the volume, the price band, and the role of the buyer.

Sources: SEC Form 4 filings submitted via EDGAR and reviewed by InsiderBuying.com, covering insider transactions at Kodiak Sciences Inc. reported with a transaction date of September 29th, 2026.

Informational only, not investment advice.